SynthesisBone marrow transplantation2025

Real-world outcomes of brentuximab vedotin as consolidation therapy after autologous stem cell transplantation in relapsed/refractory Hodgkin lymphoma: A systematic review and meta-analysis.

Anna Sureda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.